Provided are novel crystalline and amorphous forms of ibandronic acid, methods for their preparation, and pharmaceutical compositions containing them. Also provided are methods for purifying and assaying ibandronic acid in any crystalline form (or amorphous).
申请公布号
WO2006002348(A8)
申请公布日期
2007.06.21
申请号
WO2005US22410
申请日期
2005.06.22
申请人
TEVA PHARMACEUTICAL INDUSTIES LTD.;TEVA PHARMACEUTICAL USA, INC.;BAYER, THOMAS;LIFSHITZ-LIRON, REVITAL;PERUTSKI, INNA;PINCHASOV, MICHAEL
发明人
BAYER, THOMAS;LIFSHITZ-LIRON, REVITAL;PERUTSKI, INNA;PINCHASOV, MICHAEL